Niagen Bioscience Announces a Newly Published Analysis of Past Clinical Studies Demonstrating Niagen® (Patented Nicotinamide Riboside, NR) Supplementation Improved a Muscle-Specific Marker of Biologi

Go back to Niagen Bioscience Announces a Newly Published Analysis of Past Clinical Studies Demonstrating Niagen® (Patented Nicotinamide Riboside, NR) Supplementation Improved a Muscle-Specific Marker of Biologi
(NASDAQ: NAGE) Delayed: 3.05 +0.04 (1.33%)
Previous Close $3.01    52 Week High $ 
Open $3.02    52 Week Low $ 
Day High $3.06    P/E N/A 
Day Low $2.98    EPS $ 
Volume 618,996